NCT03365882 · Interventional trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Overall registry status Completed
Phase 2
Conditions Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma, Recurrent Colon Carcinoma, Recurrent Rectal Carcinoma, Stage III Colon Cancer AJCC v7, Stage III Rectal Cancer AJCC v7, Stage IIIA Colon Cancer AJCC v7, Stage IIIA Rectal Cancer AJCC v7, Stage IIIB Colon Cancer AJCC v7, Stage IIIB Rectal Cancer AJCC v7, Stage IIIC Colon Cancer AJCC v7, Stage IIIC Rectal Cancer AJCC v7, Stage IV Colon Cancer AJCC v7, Stage IV Rectal Cancer AJCC v7, Stage IVA Colon Cancer AJCC v7, Stage IVA Rectal Cancer AJCC v7, Stage IVB Colon Cancer AJCC v7, Stage IVB Rectal Cancer AJCC v7
Delaware Valley sites
- Bryn Mawr Hospital · Bryn Mawr, PA · Montgomery County
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- Inspira Medical Center Mullica Hill · Mullica Hill, NJ · Gloucester County
- Lankenau Medical Center · Wynnewood, PA · Montgomery County
- Main Line Health Center-Collegeville · Collegeville, PA · Montgomery County
- Main Line Health Center-Exton · Exton, PA · Chester County
- Paoli Memorial Hospital · Paoli, PA · Chester County
- Riddle Memorial Hospital · Media, PA · Delaware County
- Temple University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory